Healthpeak Properties Inc (NYSE: DOC) on Friday, soared 1.60% from the previous trading day, before settling in for the closing price of $17.55. Within the past 52 weeks, DOC’s price has moved between $15.71 and $21.28.
Over the past five-year period, the growth rate of yearbook sales for the company of the Real Estate sector was 52.84%. The company achieved an average annual earnings per share of -97.36%. With a float of $692.65 million, this company’s outstanding shares have now reached $694.95 million.
Healthpeak Properties Inc (DOC) Breakdown of a Key Holders of the stock
Observing investor behavior towards REIT – Healthcare Facilities industry stocks is more important than anything else. The insider ownership of Healthpeak Properties Inc is 0.33%, while institutional ownership is 96.68%. The most recent insider transaction that took place on Aug 06 ’25, was worth 24,730. In this transaction Director of this company bought 1,450 shares at a rate of $17.05, taking the stock ownership to the 810,016 shares. Before that another transaction happened on Aug 04 ’25, when Company’s President and CEO bought 1,490 for $16.83, making the entire transaction worth $25,077. This insider now owns 211,906 shares in total.
Healthpeak Properties Inc (DOC) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.05 earnings per share (EPS) for the period topping the consensus outlook (set at 0.05) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -97.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.54% during the next five years compared to 52.84% growth over the previous five years of trading.
Healthpeak Properties Inc (NYSE: DOC) Trading Performance Indicators
Healthpeak Properties Inc (DOC) is currently performing well based on its current performance indicators. A quick ratio of 101.40 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.52. Likewise, its price to free cash flow for the trailing twelve months is 10.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.06, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.30 in one year’s time.
